Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

PARP-8 Inhibitors

PARP-8 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of poly(ADP-ribose) polymerase 8 (PARP-8), a member of the PARP family of enzymes. PARP-8 is involved in various cellular processes, particularly those related to DNA repair, chromatin structure regulation, and post-translational modifications. Like other PARP enzymes, PARP-8 catalyzes the addition of ADP-ribose units to target proteins, a process known as ADP-ribosylation. This modification influences a variety of cellular functions, including protein-protein interactions, signaling pathways, and the maintenance of genome integrity. By inhibiting PARP-8, these compounds interfere with its ability to regulate ADP-ribosylation, thereby impacting key molecular processes within the cell.

The mechanism of PARP-8 inhibitors involves binding to the catalytic domain of the enzyme, blocking its ability to transfer ADP-ribose units to substrates. This inhibition affects various biological functions, particularly those involved in cellular stress responses and DNA damage signaling. Researchers use PARP-8 inhibitors to investigate the specific roles of PARP-8 in cellular processes, distinguishing its function from other members of the PARP family. This provides a better understanding of how PARP-8 regulates post-translational modifications and contributes to overall cellular homeostasis. The inhibition of PARP-8 also allows for a deeper exploration of the enzyme's role in regulating chromatin structure, gene expression, and cellular responses to environmental stress. These inhibitors offer important tools for dissecting the molecular functions of PARP-8 and its influence on cell biology, providing valuable insights into how ADP-ribosylation controls various aspects of cellular behavior.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$206.00
$299.00
$485.00
10
(1)

A known inhibitor of PARP1 and PARP2; it's uncertain but possible it could affect PARP-8.

Rucaparib

283173-50-2sc-507419
5 mg
$150.00
(0)

Another inhibitor for PARP1 and PARP2; might influence PARP-8 activity.

Talazoparib

1207456-01-6sc-507440
10 mg
$795.00
(0)

Inhibits PARP enzymes; potential for PARP-8 inhibition.

Niraparib

1038915-60-4sc-507492
10 mg
$150.00
(0)

Targets several PARP enzymes; its effect on PARP-8 is uncertain.

Veliparib

912444-00-9sc-394457A
sc-394457
sc-394457B
5 mg
10 mg
50 mg
$178.00
$270.00
$712.00
3
(0)

Another PARP1/2 inhibitor; potential influence on PARP-8 is not clear.

3-Aminobenzamide

3544-24-9sc-3501
sc-3501B
sc-3501A
100 mg
1 g
5 g
$15.00
$36.00
$51.00
18
(1)

A classic PARP inhibitor; its specificity across the PARP family is not well detailed.

PARP Inhibitor VIII, PJ34

344458-15-7sc-204161
sc-204161A
1 mg
5 mg
$57.00
$139.00
20
(1)

Broad-spectrum PARP inhibitor; exact influence on PARP-8 is uncertain.

AG 14699

459868-92-9sc-480370
25 mg
$13400.00
(0)

PARP1/2 inhibitor; potential for PARP-8 influence is uncertain.

UPF 1069

1048371-03-4sc-361396
sc-361396A
5 mg
25 mg
$89.00
$351.00
1
(0)

A PARP2 inhibitor; its effect on PARP-8 is uncertain.

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
$35.00
$115.00
$515.00
26
(1)

Though primarily a tankyrase inhibitor, it affects the PARP family; influence on PARP-8 remains uncertain.